1/30/18 Published It had been more than 5 years since the first case of Middle East Respiratory Syndrome coronavirus infection (MERS-CoV) was recorded, but no specific treatment has been investigated in randomized clinical trials. https://t.co/oFqauvQjEn
"Results from in vitro and animal studies suggest that a combination of #lopinavir/#ritonavir [i.e. #Kaletra] and interferon-β1b (IFN-β1b) may be effective against #MERS-CoV," another species of #coronavirus https://t.co/xc26wBo5gg
RT @nataliexdean: 4/8 The MIRACLE trial is ongoing in Saudi Arabia to test lopinavir/ritonavir and interferon against MERS, but the pace of…
@Songadiya @nut_meggg @QuakeFury I didn't say otherwise (about HIV patient susceptibility), but that's not the point. The point is, protease inhibitor use for COVID-19 is not proof of HIV gene editing. Their use was considered for MERS some years ago. http